1.
malignant hyperthermia is a fatal condition which occurred due to hypermetabolism of skeletal muscles. It is an inherited disorder with an abnormal ryanodine receptor.
aetiology
Abnormal ryanodine receptor interferes with the regulation of calcium in the muscle, results in massive muscle reaction
signs and symptoms
EARLY SIGNS
LATER SIGNS
drugs associated with malignant hyperthermia
volatile anaesthetic gases: halothane, sevoflurane, desflurane, isoflurane, enflurane
depolarizing muscle relaxants: suxamethonium, decamethonium.
interventions
2.
the direct-acting skeletal muscle relaxant is the drug of classification of dantrolene, used as an antidote for malignant hyperthermia.
if any signs of developing malignant hyperthermia with triggering medicine, immediately stop the medicine. administer dantrolene (dantrium). it relaxes the muscle and ceases massive muscle metabolism.
succinylcholine is the depolarising agent which has a short term action of 5 minutes. no cholinergic agents are used currently to reverse the reaction other than time. use of cholinergic worsens the condition. the only management is the administration of artificial respiration and gives time to subside. if the effect is prolonging, intubation and use of ventilator till the effect subside.
Describe the etiology, signs, and symptoms of malignant hyperthermia; the drugs associated with a high risk...
Describe the main effects of cholinesterase inhibitors on structures controlled by the autonomic nervous system and on skeletal muscle, and state the general mechanism by which these effects occur. Compare and contrast the effects of the cholinesterase inhibitors with those of bethanechol, which was described as the most representative muscarinic agonist (see Chapter 14). State the main clinical uses of cholinesterase inhibitors and precautions for and contraindications to their use. Recognize the meaning and importance of the term quaternary when...
1. Describe the anatomy of the somatic nervous system, the key transmitter and receptor type involved in skeletal muscle activation, and the physiologic consequences of activating those cell receptors. 2. Compare and contrast the mechanisms of action of nondepolarizing and depolarizing neuromuscular blocking agents and state how these actions influence the use of one class rather than the other in specified clinical situations. 3. Identify three specific uses for neuromuscular blocking agents and describe the monitoring and other measures necessary...